Samir R. Patel
Equibles does not estimate personal net worth.
Get an email with a short summary when Akari Therapeutics Plc publishes a filing, an earnings call transcript or a press release.
Get AKTX alertsAbout Samir R. Patel
Samir R. Patel is recorded as CEO at Akari Therapeutics Plc (AKTX). The newest filing on record that lists Samir R. Patel as CEO at Akari Therapeutics Plc (AKTX) is dated June 3, 2024. The proxy statement of Akari Therapeutics Plc reports total compensation of $324,985 for Samir R. Patel in fiscal 2025. Disclosed compensation is on record for 3 fiscal years. Akari Therapeutics Plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Akari Therapeutics Plc includes Abizer Gaslightwala (CEO and Board Member), Samir R. Patel, M.D. (CEO), Hoyoung Huh (Chairman and Board Member) and 6 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed June 3, 2024
Company network
Leadership on record at Akari Therapeutics Plc
- Abizer Gaslightwala CEO, Board Member
- Samir R. Patel, M.D. CEO
- Hoyoung Huh Chairman, Board Member
- Kameel Farag CFO
- Samir Patel CFO
- Torsten Hombeck CFO
- James Neal Board Member
- Robert Bazemore Board Member
- Sandip Patel Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Akari Therapeutics Plc (AKTX) | Former President and Chief Executive Officer | — | $324,985 |
| 2024 | Akari Therapeutics Plc (AKTX) | Former President and Chief Executive Officer | — | $435,767 |
| 2023 | Akari Therapeutics Plc (AKTX) | President and Chief Executive Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.